ArticleNeurology(R) neuroimmunology & neuroinflammation2020

Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy.

Gerd Haga Bringeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.